Literature DB >> 20148694

Growth of injected melanoma cells is suppressed by whole body exposure to specific spatial-temporal configurations of weak intensity magnetic fields.

Jing H Hu1, Linda S St-Pierre, Carly A Buckner, Robert M Lafrenie, Michael A Persinger.   

Abstract

PURPOSE: To measure the effect of exposure to a specific spatial-temporal, hysiologically-patterned electromagnetic field presented using different geometric configurations on the growth of experimental tumours in mice.
METHODS: C57b male mice were inoculated subcutaneously with B16-BL6 melanoma cells in two blocks of experiments separated by six months (to control for the effects of geomagnetic field). The mice were exposed to the same time-varying electromagnetic field nightly for 3 h in one of six spatial configurations or two control conditions and tumour growth assessed.
RESULTS: Mice exposed to the field that was rotated through the three spatial dimensions and through all three planes every 2 sec did not grow tumours after 38 days. However, the mice in the sham-field and reference controls showed massive tumours after 38 days. Tumour growth was also affected by the intensity of the field, with mice exposed to a weak intensity field (1-5 nT) forming smaller tumours than mice exposed to sham or stronger, high intensity (2-5 microT) fields. Immunochemistry of tumours from those mice exposed to the different intensity fields suggested that alterations in leukocyte infiltration or vascularisation could contribute to the differences in tumour growth.
CONCLUSIONS: Exposure to specific spatial-temporal regulated electromagnetic field configurations had potent effects on the growth of experimental tumours in mice.

Entities:  

Mesh:

Year:  2010        PMID: 20148694     DOI: 10.3109/09553000903419932

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  7 in total

1.  Inhibition of cancer cell growth by exposure to a specific time-varying electromagnetic field involves T-type calcium channels.

Authors:  Carly A Buckner; Alison L Buckner; Stan A Koren; Michael A Persinger; Robert M Lafrenie
Journal:  PLoS One       Date:  2015-04-14       Impact factor: 3.240

2.  Optimization of a therapeutic electromagnetic field (EMF) to retard breast cancer tumor growth and vascularity.

Authors:  Ivan L Cameron; Marko S Markov; W Elaine Hardman
Journal:  Cancer Cell Int       Date:  2014-12-07       Impact factor: 5.722

3.  Effect of low frequency magnetic fields on melanoma: tumor inhibition and immune modulation.

Authors:  Yunzhong Nie; Leilei Du; Yongbin Mou; Zhenjun Xu; Leihua Weng; Youwei Du; Yanan Zhu; Yayi Hou; Tingting Wang
Journal:  BMC Cancer       Date:  2013-12-06       Impact factor: 4.430

4.  Human Biofield Therapy and the Growth of Mouse Lung Carcinoma.

Authors:  Peiying Yang; Yan Jiang; Patrea R Rhea; Tara Coway; Dongmei Chen; Mihai Gagea; Sean L Harribance; Lorenzo Cohen
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

5.  Ultraweak Photon Emissions as a Non-Invasive, Early-Malignancy Detection Tool: An In Vitro and In Vivo Study.

Authors:  Nirosha J Murugan; Michael A Persinger; Lukasz M Karbowski; Blake T Dotta
Journal:  Cancers (Basel)       Date:  2020-04-18       Impact factor: 6.639

Review 6.  Pathological impact and medical applications of electromagnetic field on melanoma: A focused review.

Authors:  Yunxiao Duan; Xiaowen Wu; Ziqi Gong; Qian Guo; Yan Kong
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

7.  Human Biofield Therapy Modulates Tumor Microenvironment and Cancer Stemness in Mouse Lung Carcinoma.

Authors:  Peiying Yang; Patrea R Rhea; Tara Conway; Sita Nookala; Venkatesh Hegde; Mihai Gagea; Nadim J Ajami; Sean L Harribance; Jewel Ochoa; Jagannadha K Sastry; Lorenzo Cohen
Journal:  Integr Cancer Ther       Date:  2020 Jan-Dec       Impact factor: 3.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.